Advertisement
Advertisement

ITRM

ITRM logo

Iterum Therapeutics plc Ordinary Share

0.99
USD
-0.01
-0.51%
Jun 13, 15:59 UTC -4
Closed
exchange

After-Market

1.00

+0.01
+0.91%

Iterum Therapeutics plc Ordinary Share Profile

About

Iterum Therapeutics plc is a clinical-stage pharmaceutical company. It develops and markets therapies to address unmet medical needs, as well as provides anti-infectives to treat multi-drug resistant pathogens. The company's product pipeline consists of uncomplicated urinary tract infections, complicated urinary tract infections and complicated intra abdominal infections. Iterum Therapeutics plc is based in Dublin, Ireland.

Info & Links

CEO

Corey N. Fishman

Headquarters

3 DUBLIN LANDINGS, NORTH WALL QUAY
DUBLIN, L2 D01 H104, IRELAND

Industry

Medical Drugs

Sector

Medical

Website

www.iterumtx.com

Auditor

KPMG

Share holders

12

Employees

9

Iterum Therapeutics plc Ordinary Share Statistics

Valuation Measures

Market Capitalization2

40M

Enterprise Value

48.05M

Enterprise Value/EBITDA(ttm)

-3.51

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

31.22%

Return on Assets(ttm)

-90.85%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

-342.00K

EBITDA(ttm)3

-13.70M

Net Income Available to Common(ttm)

-22.56M

Diluted EPS(ttm)

-1.31

Share Statistics

Beta (5Y Monthly)

2.28

52-Week Change

-13.83%

S&P 500 52-Week Change

9.20%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

31.40M

% Held by Insiders

9.20%

% Held by Institutions

9.21%

Balance Sheet

Total Cash(mrq)

12.65M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

20.70M

Total Debt/Equity(mrq)

-810.69%

Current Ratio(mrq)

3.72%

Quick Ratio(mrq)

1.41%

Book Value Per Share(mrq)

-0.07

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.09

Free Cash Flow(ytd)

-3.06M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement